November 9, 2014
As we get closer to the holidays, many people look for ways to cut back on sugar and other indulgences so that when the New Year rolls around, they won’t have to work so hard to lose those extra pounds. While it is a good idea to avoid sugar altogether, using the artificial sweeteners Splenda or Aspartame might be even worse. There are numerous reasons you should avoid the stuff in little yellow packages (or pink, or blue). Here is why.
Donald Rumsfeld, the very same politician who supports GMOs, is perhaps the singular man who got Splenda onto the market after the FDA initially refused it. If you have gotten sick from consuming this toxic substance, you can thank him, along with its makers. Splenda was created by the British company Tate & Lyle along with the pharmaceutical giant Johnson & Johnson.
Perhaps you remember when the Coca-Cola company launched its ad campaign to fight obesity back in the early 80s? This was all part of a ploy to begin the use of aspartame, whose patent was once owned by none other than Monsanto! Ironically, there are numerous studies that show this stuff causes obesity. It doesn’t prevent obesity.
Before they started selling you Splenda, it was called NutraSweet. In 1985, Monsanto purchased G.D. Searle, the chemical company that held the patent to aspartame, the active ingredient in NutraSweet, as well as Splenda and many other artificial sweeteners. Is Splenda safe? It depends who you ask.
Let’s look at a little timeline, shall we?
- 1901: Monsanto Chemical Works is formed.
- 1976: When Ford loses the 1976 election, Rumsfeld returns to private business life, and is named president and CEO of the pharmaceutical corporation G. D. Searle & Company, during which time he leads the legalization of Aspartame.
- 1977: Monsanto stops producing PCBs.
- 1997: Monsanto businesses are spun off as Solutia Inc.
- 1999: John Hunter is named chairman and CEO.
- 2000: Monsanto’s Pharmaceutical Services Division is created. Monsanto also merges with the drug-maker Pharmacia & UpJohn Inc., which took control of the Searle pharmaceutical operations, and the current Monsanto Co. was incorporated as a subsidiary in October 2000.
- 2002: PCB trial results in sharp drop in stock price.